Employees wearing personal protective equipment (PPE) put on gloves as they prepare to work at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479901
General Director of Vector-BiAlgam Leonid Nikulin attends a syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479900
A view shows packages of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479790
An employee demonstrates a package of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479789
Employees wearing personal protective equipment (PPE) work at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479788
Employees wearing personal protective equipment (PPE) work at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479787
Employees wearing personal protective equipment (PPE) work at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479786
An employee wearing personal protective equipment (PPE) works at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479785
A view shows syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479784
Employees wearing personal protective equipment (PPE) work at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479783
An employee wearing personal protective equipment (PPE) works at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479782
A view shows syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479781
An employee wearing personal protective equipment (PPE) works at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479780
A view shows syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479779
An employee wearing personal protective equipment (PPE) works at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479778
Employees wearing personal protective equipment (PPE) work at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479777
A view shows syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479776
A view shows syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479775
Employees wearing personal protective equipment (PPE) work at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479774
A view shows syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479773
Employees wearing personal protective equipment (PPE) work at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479772
An employee wearing personal protective equipment (PPE) works at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479770
An employee wearing personal protective equipment (PPE) works at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479771
A view shows syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479769
A view shows syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479768
A view shows syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.04.03.2021#6479767
